CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?

Lymphocytic infiltration is often seen in breast cancer and has been suggested as a marker of host anti-tumor response but its importance in prognosis remains controversial. Our recent study demonstrated an association between tumor-infiltrating CD8(+) T lymphocytes in invasive breast cancer and bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Sahar, Lee, Andrew, Ellis, Ian, Green, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382867/
https://www.ncbi.nlm.nih.gov/pubmed/22737616
http://dx.doi.org/10.4161/onci.18614
_version_ 1782236563205259264
author Mahmoud, Sahar
Lee, Andrew
Ellis, Ian
Green, Andrew
author_facet Mahmoud, Sahar
Lee, Andrew
Ellis, Ian
Green, Andrew
author_sort Mahmoud, Sahar
collection PubMed
description Lymphocytic infiltration is often seen in breast cancer and has been suggested as a marker of host anti-tumor response but its importance in prognosis remains controversial. Our recent study demonstrated an association between tumor-infiltrating CD8(+) T lymphocytes in invasive breast cancer and better prognosis.
format Online
Article
Text
id pubmed-3382867
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-33828672012-06-26 CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker? Mahmoud, Sahar Lee, Andrew Ellis, Ian Green, Andrew Oncoimmunology Author's View Lymphocytic infiltration is often seen in breast cancer and has been suggested as a marker of host anti-tumor response but its importance in prognosis remains controversial. Our recent study demonstrated an association between tumor-infiltrating CD8(+) T lymphocytes in invasive breast cancer and better prognosis. Landes Bioscience 2012-05-01 /pmc/articles/PMC3382867/ /pubmed/22737616 http://dx.doi.org/10.4161/onci.18614 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Mahmoud, Sahar
Lee, Andrew
Ellis, Ian
Green, Andrew
CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
title CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
title_full CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
title_fullStr CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
title_full_unstemmed CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
title_short CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
title_sort cd8(+) t lymphocytes infiltrating breast cancer: a promising new prognostic marker?
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382867/
https://www.ncbi.nlm.nih.gov/pubmed/22737616
http://dx.doi.org/10.4161/onci.18614
work_keys_str_mv AT mahmoudsahar cd8tlymphocytesinfiltratingbreastcancerapromisingnewprognosticmarker
AT leeandrew cd8tlymphocytesinfiltratingbreastcancerapromisingnewprognosticmarker
AT ellisian cd8tlymphocytesinfiltratingbreastcancerapromisingnewprognosticmarker
AT greenandrew cd8tlymphocytesinfiltratingbreastcancerapromisingnewprognosticmarker

Ejemplares similares